• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus.

作者信息

Lorenzo M M, Blasco R

机构信息

Centro de Investigación en Sanidad Animal, INIA, Valdeolmos, Madrid, Spain.

出版信息

Biotechniques. 1998 Feb;24(2):308-13. doi: 10.2144/98242rr03.

DOI:10.2144/98242rr03
PMID:9494734
Abstract

Vaccinia virus expression systems allow efficient expression of genes and facilitate functional studies of expressed proteins in cultured mammalian cells. We designed and tested a rapid method to introduce defined mutations in genes inserted and expressed in vaccinia virus. PCR mutagenesis is used to construct a recombination cassette that contains: (i) the mutated exogenous gene, (ii) recombination flanks to direct insertion into the virus genome and (iii) a selectable gene to allow easy isolation of recombinant viruses. To generate recombinant viruses, the recombination cassette is transfected into vaccinia virus-infected cells. The procedure does not require cloning, and the mutated gene versions are inserted directly into the vaccinia virus genome downstream of a vaccinia virus strong promoter. The method was tested by introducing a point mutation into Aequorea victoria green fluorescent protein (GFP), known to alter the fluorescence absorption and emission spectra of the protein. This system should facilitate and speed the isolation of virus recombinants expressing mutated versions of any given gene and can be adapted to random mutagenesis procedures, exon shuffling or other PCR-based mutagenesis protocols.

摘要

相似文献

1
PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus.
Biotechniques. 1998 Feb;24(2):308-13. doi: 10.2144/98242rr03.
2
A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.一种新型痘苗病毒表达系统,无需选择标记、质粒和细菌宿主即可构建重组体。
J Gen Virol. 1995 Dec;76 ( Pt 12):2957-62. doi: 10.1099/0022-1317-76-12-2957.
3
An efficient method for generating poxvirus recombinants in the absence of selection.一种在无选择压力情况下生成痘病毒重组体的有效方法。
Viruses. 2011 Mar;3(3):217-32. doi: 10.3390/v3030217.
4
Construction and evaluation of a new triple-gene expression cassette vaccinia virus shuttle vector.构建与评价一种新型三重基因表达盒痘苗病毒穿梭载体
J Virol Methods. 2012 Nov;185(2):175-83. doi: 10.1016/j.jviromet.2012.06.022. Epub 2012 Jul 2.
5
A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.一种基于聚合酶链式反应(PCR)的用于操作痘苗病毒基因组的方法,该方法无需克隆。
Biotechniques. 1992 Nov;13(5):764-71.
6
BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.BiZyme:一种通过荧光和抗生素抗性介导痘苗病毒重组体筛选的新型融合蛋白。
Biotechniques. 2002 May;32(5):1178, 1180, 1182-7. doi: 10.2144/02325dd08.
7
Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry.重组痘苗病毒表达的绿色荧光蛋白可通过流式细胞术早期检测受感染的细胞。
J Immunol Methods. 1998 Nov 1;220(1-2):115-21. doi: 10.1016/s0022-1759(98)00156-2.
8
The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.标记基因交换与荧光激活细胞分选相结合提高了人用重组改良安卡拉痘苗病毒疫苗生产的效率。
J Virol Methods. 2010 Feb;163(2):195-204. doi: 10.1016/j.jviromet.2009.09.016. Epub 2009 Sep 22.
9
Transient selection during vaccinia virus recombination with insertion vectors without selectable markers.
Biotechniques. 1997 May;22(5):906-10. doi: 10.2144/97225st03.
10
MAVERICC: Marker-free Vaccinia Virus Engineering of Recombinants through in vitro CRISPR/Cas9 Cleavage.MAVERICC:通过体外 CRISPR/Cas9 切割实现无标记痘苗病毒重组子的工程改造。
J Mol Biol. 2021 Apr 30;433(9):166896. doi: 10.1016/j.jmb.2021.166896. Epub 2021 Feb 24.

引用本文的文献

1
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.痘病毒作为基因治疗载体:构建表达治疗性转基因的痘病毒载体
Methods Mol Biol. 2019;1937:189-209. doi: 10.1007/978-1-4939-9065-8_11.
2
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.多基因工程无标记痘病毒的快速构建及临床级溶瘤痘苗病毒的特性研究
Mol Ther Methods Clin Dev. 2017 Sep 30;7:112-122. doi: 10.1016/j.omtm.2017.09.007. eCollection 2017 Dec 15.
3
A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.
一种痘苗病毒重组体转录一种甲病毒复制子并表达甲病毒结构蛋白,导致甲病毒感染性单周期颗粒的包装。
PLoS One. 2013 Oct 9;8(10):e75574. doi: 10.1371/journal.pone.0075574. eCollection 2013.
4
Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.使用辛德毕斯病毒复制子单独表达的痘苗病毒细胞外被膜病毒包膜蛋白的细胞内定位。
J Virol. 2000 Nov;74(22):10535-50. doi: 10.1128/jvi.74.22.10535-10550.2000.